Global geographical overlap of aflatoxin and hepatitis C: controlling risk factors for liver cancer worldwide

References

• Abdel-Wahab , M , El-Ghawalby , N , Mostafa , M , Sultan , A , El-Sadany , M , Fathy , O , Salah , T and Ezzat , F . 2007 . Epidemiology of hepatocellular carcinoma in lower Egypt, Mansoura Gastroenterology Center . Hepatogastroenterology , 54 : 157 – 162 .
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab , M , Mostafa , M , Sabry , M , el-Farrash , M and Yousef , T . 2008 . Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center study . Hepatogastroenterology , 55 : 1754 – 1759 .
   PubMed Web of Science ®Google Scholar
• Armstrong , GL , Wasley , A , Simard , EP , McQuillan , GM , Kuhnert , WL and Alter , MJ . 2006 . The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 . Ann Intern Med , 144 : 705 – 714 .
   PubMed Web of Science ®Google Scholar
• Baatarkhuu , O , Kim , dY , Bat-Ireedui , P and Han , K-H . 2011 . Current situation of hepatocellular carcinoma in Mongolia . Oncology , 81 ( Suppl. 1 ) : 148 – 151 .
   PubMed Web of Science ®Google Scholar
• Barnes , E , Folgori , A , Capone , S , Swadling , L , Aston , S , Kurioka , A , Meyer , J , Huddart , R , Smith , K Townsend , R . 2012 . Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man . Sci Transl Med , 4 : 115ra1
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). 2011a. Hepatitis C information for health professionals [Internet]; [cited 2011 Aug 10]. Available from: http://www.cdc.gov/hepatitis/HCV/HCVfaq.htm#section1
   Google Scholar
• Centers for Disease Control and Prevention (CDC). 2011b. Incidence of acute hepatitis C, by age group – United States, 1992–2009 [Internet]; [cited 2011 Sep 24]. Available from: http://www.cdc.gov/hepatitis/Statistics/2009Surveillance/Slide4.2.htm
   Google Scholar
• Centers for Disease Control and Prevention (CDC). 2011c. National prevention strategy [Internet]; [cited 2011 Sep 9]. Available from: http://www.cdc.gov/hepatitis/hcv/Strategy/NatHepCPrevStrategy.htm
   Google Scholar
• Chang , MH , You , SL , Chen , CJ , Liu , CJ , Lee , CM , Lin , SM , Chu , HC , Wu , TC , Yang , SS , Kuo , HS and Chen , DS . 2009 . Decreased incidence of hepatocellular carcinoma in hepatitis B vaccines: a 20-year follow-up study . J Natl Cancer Inst , 101 : 1348 – 1355 .
   PubMed Web of Science ®Google Scholar
• Eisentein , M . 2011 . Vaccines: a moving target . Nature , 474 : S16 – S17 .
   PubMed Web of Science ®Google Scholar
• El-Kafrawy , SA , Abdel-Hamid , M , El-Daly , M , Nada , O , Ismail , A , Ezzat , S , Abdel-Latif , S , Abdel-Hamid , A , Shields , PG and Loffredo , C . 2005 . P53 mutations in hepatocellular carcinoma patients in Egypt . Int J Hyg Environ Health , 208 : 263 – 270 .
   PubMed Web of Science ®Google Scholar
• Franceschi , S and Raza , SA . 2009 . Epidemiology and prevention of hepatocellular carcinoma . Cancer Lett , 286 : 5 – 8 .
   PubMed Web of Science ®Google Scholar
• Frank , C , Mohamed , MK , Strickland , GT , Lavancy , D , Arthur , RR , Magder , LS , El Khoby , T , Abdel-Wahab , Y , Aly Ohn , ES , Anwar , W and Sallam , I . 2000 . The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt . Lancet , 355 : 887 – 891 .
   PubMed Web of Science ®Google Scholar
• Groopman , JD , Kensler , TW and Wild , CP . 2008 . Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries . Annu Rev Public Health , 29 : 187 – 203 .
   PubMed Web of Science ®Google Scholar
• Hall , AJ and Wild , CP . 2003 . Liver cancer in low and middle income countries . Br Med J , 26 : 994 – 995 .
   Web of Science ®Google Scholar
• Immunization Action Coalition (IAC). 2007. Hepatitis A, B, and C: learn the differences [Internet]; [cited 2012 Dec 12]. Available from: http://www.immunize.org/guide/aov12_appa_hepatitis.pdf
   Google Scholar
• International Agency for Research in Cancer (IARC). 2008. GLOBOCAN [Internet]; [cited 2011 Aug 8]. Available from: http://www.iarc.fr/
   Google Scholar
• Jeannot E, Boorman GA, Kosyk O, Bradford BU, Shymoniak S, Tumurbaatar B, Weinman SA, Melnyk SB, Tryndyak V, Pogribny IP, Rusyn I. 2012. Increased incidence of aflatoxin B1-induced liver tumors in hepatitis virus C transgenic mice. Int J Cancer. 130:1347–1356
   Google Scholar
• Jiang , W , Wang , XW , Unger , T , Forgues , M , Kim , JW , Hussain , SP , Bowman , E , Spillare , EA , Lipsky , MM Meck , JM . 2010 . Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line . Int J Cancer , 127 : 1011 – 1020 .
   PubMed Web of Science ®Google Scholar
• Khlangwiset , P and Wu , F . 2010 . Costs and efficacy of public health interventions to reduce aflatoxin-induced human disease . Food Addit Contam A , 27 : 998 – 1014 .
   Web of Science ®Google Scholar
• Kirk , GD , Lesi , OA , Mendy , M , Szymanska , K , Whittle , H , Goedert , JJ , Hainaut , P and Montesano , R . 2005 . 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma . Oncogene , 24 : 5858 – 5867 .
   PubMed Web of Science ®Google Scholar
• Lata , J . 2010 . Chronic liver diseases as liver tumor precursors . Dig Dis , 28 : 596 – 599 .
   PubMed Web of Science ®Google Scholar
• Lavanchy , D . 2011 . Evolving epidemiology of hepatitis C virus . Clin Microbiol Infect , 17 : 107 – 115 .
   PubMed Web of Science ®Google Scholar
• Liu , Y , Chang , CH , Marsh , GM and Wu , F . 2012 . Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis . Eur J Cancer , 48 : 2125 – 2136 .
   PubMed Web of Science ®Google Scholar
• Liu , Y and Wu , F . 2010 . Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment . Environ Health Perspect , 118 : 818 – 824 .
   PubMed Web of Science ®Google Scholar
• McGivern , DR and Lemon , SM . 2011 . Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer . Oncogene , 30 : 1969 – 1983 .
   PubMed Web of Science ®Google Scholar
• McGlynn , KA and London , WT . 2011 . The global epidemiology of hepatocellular carcinoma: present and future . Clin Liver Dis , 15 : 223 – 243 .
   PubMed Web of Science ®Google Scholar
• Montalto , G , Cervello , M , Giannitrapani , L , Dantona , F , Terranova , A and Castagnetta , LA . 2002 . Epidemiology, risk factors, and natural history of hepatocellular carcinoma . Ann N Y Acad Sci , 963 : 13 – 20 .
   PubMed Web of Science ®Google Scholar
• Ni , YH and Chen , DS . 2010 . Hepatitis B vaccination in children: the Taiwan experience . Pathol Bio (Paris) , 58 : 296 – 300 .
   PubMed Web of Science ®Google Scholar
• Perz , JF , Armstrong , GI , Farrington , LA , Hutin , YJ and Bell , BP . 2006 . The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide . J Hepatol , 45 : 529 – 538 .
   PubMed Web of Science ®Google Scholar
• Prati , D . 2006 . Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review . J Hepatol , 45 : 607 – 616 .
   PubMed Web of Science ®Google Scholar
• Qian , GS , Ross , RK , Yu , MC , Yuan , JM , Gao , YT , Henderson , BE , Wogan , GN and Groopman , JD . 1994 . A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China . Cancer Epidemiol Biomarkers Prev , 3 : 3 – 10 .
   PubMed Web of Science ®Google Scholar
• Santos , C and Herrine , SK . 2010 . Making the best of a bad situation: early chronic nosocomial HCV infection . Dig Dis Sci , 55 : 1509 – 1511 .
   PubMed Web of Science ®Google Scholar
• Sugita-Konishi , Y , Sato , T , Saito , S , Nakajima , M , Tabata , S , Tanaka , T , Norizuki , H , Itoh , Y , Kai , S Sugiyama , K . 2010 . Exposure to aflatoxins in Japan: risk assessment for aflatoxin B1 . Food Addit Contam A , 27 : 365 – 372 .
   Web of Science ®Google Scholar
• Thun , M , DeLancey , JO , Center , MM , Jemal , A and Ward , EM . 2010 . The global burden of cancer: priorities for prevention . Carcinogenesis , 31 : 100 – 110 .
   PubMed Web of Science ®Google Scholar
• Viviani , S , Carrieri , P , Bah , E , Hall , AJ , Kirk , GD , Mendy , M , Montesano , R , Plymoth , A , Sam , O Van der Sande , M . 2008 . 20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer . Cancer Epidemiol Biomarkers Prev , 17 : 3216 – 3223 .
   PubMed Web of Science ®Google Scholar
• Viviani , S , Jack , A , Bah , E and Montesano , R . 1997 . Hepatocellular carcinoma: a preventable cancer . Epidemiol Prev , 21 : 129 – 136 .
   PubMedGoogle Scholar
• Wang , LY , Hatch , M , Chen , CJ , Levin , B , You , SL , Lu , SN , Wu , MH , Wu , WP , Wang , LW Wang , Q . 1996 . Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan . Int J Cancer , 67 : 620 – 625 .
   PubMed Web of Science ®Google Scholar
• Wild , CP and Gong , YY . 2010 . Mycotoxins and human disease: a largely ignored global health issue . Carcinogenesis , 31 : 71 – 82 .
   PubMed Web of Science ®Google Scholar
• Wu , F . 2004 . Mycotoxin risk assessment for the purpose of setting international regulatory standards . Environ Sci Tech , 38 : 4049 – 4055 .
   PubMed Web of Science ®Google Scholar